{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:04:35Z","timestamp":1759334675180,"version":"build-2065373602"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.jfo.2014.06.008","type":"journal-article","created":{"date-parts":[[2014,12,19]],"date-time":"2014-12-19T22:43:53Z","timestamp":1419029033000},"page":"34-40","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Neuropathie optique isch\u00e9mique non art\u00e9ritique bilat\u00e9rale au cours du traitement de l\u2019h\u00e9patite virale\u00a0C par l\u2019association interf\u00e9ron p\u00e9gyl\u00e9 et Ribavirine\u00ae"],"prefix":"10.1016","volume":"38","author":[{"given":"S.","family":"Iferkhass","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Elasri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Chatioui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Khoyaali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Bargach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Reda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Oubaaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfo.2014.06.008_bib0005","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1136\/bjo.82.3.323","article-title":"Shoichi Sato Interferon associated retinopathy","volume":"82","author":"Seiji Hayasaka","year":"1998","journal-title":"Br J Ophthalmol"},{"issue":"10","key":"10.1016\/j.jfo.2014.06.008_bib0010","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1001\/jama.1991.03470100067035","article-title":"The interferons. Mechanisms of action and clinical applications","volume":"266","author":"Baron","year":"1991","journal-title":"JAMA"},{"key":"10.1016\/j.jfo.2014.06.008_bib0015","first-page":"B60","article-title":"Traitement de l\u2019h\u00e9patite chronique C\u00a0: effets secondaires, tol\u00e9rance et qualit\u00e9 de vie","volume":"26","author":"Gournay","year":"2002","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.jfo.2014.06.008_bib0020","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1002\/hep.510270533","article-title":"Neurovisual impairment: a frequent complication of alpha-interferon treatment in chronic viral hepatitis","volume":"27","author":"Manesis","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.jfo.2014.06.008_bib0025","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1016\/S0181-5512(07)91366-2","article-title":"Complications ophtalmologiques du traitement de l\u2019h\u00e9patite C","volume":"30","author":"Sauer","year":"2007","journal-title":"J Fr. Ophtalmol."},{"key":"10.1016\/j.jfo.2014.06.008_bib0030","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1097\/01.mcg.0000135897.30038.16","article-title":"Visual side effects of pegylated interferon during therapy for chronic hepatitis C infection","volume":"38","author":"Willson","year":"2004","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.jfo.2014.06.008_bib0035","first-page":"945","article-title":"Nodules dysoriques apparus au cours du traitement par interf\u00e9ron et Ribavirine\u00ae d\u2019une h\u00e9patite C","volume":"27","author":"Av\u00e9rous","year":"2003","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.jfo.2014.06.008_bib0040","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1002\/hep.510270536","article-title":"Neurovisual complications of interferon-alpha therapy","volume":"27","author":"Fortin","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.jfo.2014.06.008_bib0045","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/j.1365-2036.2005.02365.x","article-title":"Retinal toxicity during pegylated alpha-interferon therapy forchronic hepatitis C: a multifocal electroretinogram investigation","volume":"21","author":"Chisholm","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"issue":"22","key":"10.1016\/j.jfo.2014.06.008_bib0050","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.3748\/wjg.v13.i22.3137","article-title":"Intraocular complications of IFN-\u03b1 and ribavirin therapy in patients with chronic viral hepatitis C","volume":"13","author":"S\u00e8ne","year":"2007","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1016\/j.jfo.2014.06.008_bib0055","doi-asserted-by":"crossref","first-page":"147","DOI":"10.4103\/0301-4738.60088","article-title":"Cystoid macular edema and visual loss as suequlea to interferon alpha traetement off cystemic hepatitis C","volume":"58","author":"Sheth","year":"2010","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.jfo.2014.06.008_bib0060","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/S0399-8320(05)82144-X","article-title":"Ischemic anterior optic neuropathy complicating interferon alpha-2a and ribavirin treatment for acute hepatitis C","volume":"29","author":"Yaghi","year":"2005","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.jfo.2014.06.008_bib0065","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/00041327-200312000-00003","article-title":"Interferon-alpha-associated bilateral simultaneous ischemic optic neuropathy","volume":"23","author":"Vardizer","year":"2003","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/j.jfo.2014.06.008_bib0070","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0168-8278(02)00243-X","article-title":"Visual loss during interferon-alpha therapy in hepatitis C infection","volume":"37","author":"Perlemuter","year":"2002","journal-title":"J. Hepatol"},{"key":"10.1016\/j.jfo.2014.06.008_bib0075","first-page":"117","article-title":"Pegylated interferon alpha associated optic neuropathy","volume":"30","author":"Berg","year":"2010","journal-title":"Journal Neuro-ophtalmology"},{"year":"2007","series-title":"Optic Nerve Disorders Diagnosis and Management, MD","author":"Chan","key":"10.1016\/j.jfo.2014.06.008_bib0080"},{"key":"10.1016\/j.jfo.2014.06.008_bib0085","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1159\/000027450","article-title":"Natural interferon therapy: optic nerve ischemic damage?","volume":"213","author":"Norcia","year":"1999","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.jfo.2014.06.008_bib0090","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1053\/sarh.2002.37277","article-title":"Autoimmune disease complicating antiviral therapy for hepatitis C virus infection","volume":"32","author":"Wilson","year":"2002","journal-title":"Semin Arthritis Rheum"},{"issue":"Suppl. 4","key":"10.1016\/j.jfo.2014.06.008_bib0095","doi-asserted-by":"crossref","first-page":"501s","DOI":"10.1016\/S0248-8663(02)00666-5","article-title":"Interferon alpha and auto-immunity","volume":"23","author":"Papo","year":"2002","journal-title":"Revue de m\u00e9decine interne"},{"key":"10.1016\/j.jfo.2014.06.008_bib0100","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/S0140-6736(99)00403-1","article-title":"Severe loss of vision during adjuvant interferon alfa 2b treatment for malignant melanoma","volume":"353","author":"Lohmann","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jfo.2014.06.008_bib0105","first-page":"1925","article-title":"Long-term outcome of interferon-alpha-induced thyroid autoimmunity and prognostic influence of thyroid autoantibody pattern at the end of treatment","volume":"86","author":"Carella","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jfo.2014.06.008_bib0110","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/PL00011206","article-title":"Rheumatoid arthritis induced by alpha-interferon therapy","volume":"20","author":"Passos de Souza","year":"2001","journal-title":"Clin Rheumatol"},{"issue":"4","key":"10.1016\/j.jfo.2014.06.008_bib0115","first-page":"432","article-title":"Development of sarcoidosis during interferon alpha 2b and ribavirin combination therapy for chronic hepatitis C \u2013 a case report and review of the literature","volume":"68","author":"Bolukbas","year":"2005","journal-title":"Acta Gastroenterol Belg"},{"key":"10.1016\/j.jfo.2014.06.008_bib0120","first-page":"324","article-title":"Le traitement des h\u00e9patites B et C par interf\u00e9ron alpha peut induire ou aggraver un psoriasis","volume":"19","author":"Cervoni","year":"1995","journal-title":"Gastroenterol Clin Biol"},{"issue":"9","key":"10.1016\/j.jfo.2014.06.008_bib0125","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1046\/j.1365-2036.2002.01326.x","article-title":"Meta-analysis: ribavirin-induced haemolytic anaemia in patients with chronic hepatitis C","volume":"16","author":"Chang","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jfo.2014.06.008_bib0130","first-page":"2054","article-title":"Retinal complications with elevated circulating plasma C5a associated with interferon-alpha therapy for chronic active hepatitis C","volume":"89","author":"Sugano","year":"1994","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.jfo.2014.06.008_bib0135","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1177\/112067210801800226","article-title":"Hepatitis C virus presumably associated bilateral consecutive anterior ischemic optic neuropathy","volume":"18","author":"Fodor","year":"2008","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.jfo.2014.06.008_bib0140","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.1365-2893.1997.00120.x","article-title":"The spectrum of extrahepatic manifestations of hepatitis C virus infection","volume":"4","author":"Hadziyannis","year":"1997","journal-title":"J Vir Hep"},{"key":"10.1016\/j.jfo.2014.06.008_bib0145","first-page":"247","article-title":"Autoimmune disorders associated with hepatitis C","volume":"13","author":"Marcellin","year":"1995","journal-title":"Prog Liv Dis"},{"issue":"11","key":"10.1016\/j.jfo.2014.06.008_bib0150","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1001\/archopht.1997.01100160573008","article-title":"Nonarteritic anterior ischemic optic neuropathy. A case-control study of potential risk factors","volume":"115","author":"Jacobson","year":"1997","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jfo.2014.06.008_bib0155","first-page":"257","article-title":"Surveillance ophtalmologique des patients sous interf\u00e9ron\u00a0: Pourquoi\u00a0? Comment\u00a0?","volume":"128","author":"Michel","year":"2001","journal-title":"Ann Dermatol Venereol"}],"container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S018155121400309X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S018155121400309X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:04:45Z","timestamp":1759259085000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S018155121400309X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S018155121400309X"],"URL":"https:\/\/doi.org\/10.1016\/j.jfo.2014.06.008","relation":{},"ISSN":["0181-5512"],"issn-type":[{"type":"print","value":"0181-5512"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuropathie optique isch\u00e9mique non art\u00e9ritique bilat\u00e9rale au cours du traitement de l\u2019h\u00e9patite virale\u00a0C par l\u2019association interf\u00e9ron p\u00e9gyl\u00e9 et Ribavirine\u00ae","name":"articletitle","label":"Article Title"},{"value":"Journal Fran\u00e7ais d'Ophtalmologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfo.2014.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}